Viral Infections Flashcards

1
Q

Describe the common cold

A

Symptoms = Rhinitis (inflammation of the nasal mucosa), Pharyngitis (sore throat)
No high fever, LRT involvement, or respiratory distress.
- More common in spring and fall
- Complications = Otitis media, sinus infection, exacerbation of asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the main viruses that cause common cold?

A

Rhinovirus - Main causative agent

Coronavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Rhinoviruses

A

Picornavirus family member (small RNA)

  • Non enveloped, +ssRNA genome
  • Three viral species with 100 serotypes
  • Shed in respiratory secretions and transmission through direct contact with nasal secretions, large droplets and contaminated fomites
  • extremely low inoculum needed for infection (1-3 days of incubation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe pathology of rhinoviruses

A

1) infection in nasal epithelium
2) viruses is absorbed
3) virus replicates
4) virus sheds epithelium causing host cell defenses to be activated
5) recovery via interferon and ab production (epithelium becomes regenerated with no sign of virus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the treatment of Rhinovirus

A

Treatment regimens aimed to alleviate symptoms (antihistamines, decongestants

  • antibiotics ONLY given in the case of bacterial superinfections
  • immune responses to rhinovirus infection can be long lasting in a serotype specific manner (but, many serotypes tho)
  • NO VACCINES AVAILABLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe Non-SARS coronavirus

A

Enveloped with +ssRNA genome

  • replicated in the epithelial cells of the respiratory tract
  • optimal temp of 33-35 degrees
  • transmission occurs through large droplets (3 day incubation period)
  • outbreaks common in winter and spring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Treatment and prevention of Non-SARS coronavirus

A

like rhinoviruses, the treatment for non SARS coronavirus infections is aimed to alleviate symptoms

  • No vaccine available
  • reinfection can occur despite circulating antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe adenoviruses

A

adenovirus family; non enveloped dsDNA genome

  • the adenoviral fiber proteins protrude from the 12 vertices of the capsid used for attachment and are toxic to cell
  • Lots of serotypes –> 1,2,5 causes respiratory disease
  • Transmission: oral, droplet inhalation, conjunctiva
  • replicate in epithelial cells causing tissue damage
  • may enter lymphoid tissues following acut infection (shed virus for up to 18 months)
  • NO SEASONAL PATTERN OF DISEASE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe other illnesses associated with adenovirus

A

= Pharyngoconjunctival fever - conjunctivitis, pharyngitis, fever
= More severe respiratory infections, such as croup, bronchiolitis and pneumonia
= Serotypes 40 and 41 are associated with gastrointestinal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe treatments for adenoviruses

A

treatment are aimeda t reducing symptoms

  • immunity is long-lived but serotype specific
  • live oral vaccine to serotypes 4 and 7 for military recruits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Coxsackieviruses

A

Enterovirus subfamily of picornairuses

  • nonenveloped +ssRNA genome
  • replication is fast and occurs in the cytoplasm
  • able to survive low pH conditions found in GI tract
  • Transmitted through the fecal-oral route
  • No vaccine available
  • recovery generally occurs in a couple of weeks without treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe Herpangina

A

Caused by Coxsackievirus
Symptoms:
- Abrupt onset of fever, small vesicles on the soft palate that when they rupture form small white ulcers
- Most common in children 1-7 years old
- complications can e meningitis or encephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Hand-Foot and Mouth disease

A

Caused by Coxsackievirus

  • Symptoms = fever, vesicular lesions on the soles of hands and feet and on oral areas
  • most frequent in children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are other common cold viruses

A

Influenza viruses - B and C especially
Respiratory syncytial virus - adults and school-aged children
Parainfluenza virus - adults and school-aged children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe Croup

A

Laryngotracheobronchitis

  • symptoms develop from swelling of subglottic region of the larynx (fever, brassy cough, inspiratory strider
  • radiograph: narrowing of air shadow of trachea in the subglottic area referred to “steeple sign”
  • most common in children less than 6 years
  • complication include hypoxia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the treatment of Croup

A

Treatment goal = alleviate symtpoms

  • If they have a strider at rest (severe) treat with oxygen, epinephrine, glucocorticoids to open airways
  • if they have no stridor (mild or moderate) at rest treat with humidified air and hydration
17
Q

Describe the causes of Croup

A

Parainfluenza virus:
- Type I is the most common cause of acute Croup
- Type 2-3 can also cause croup (parainfluenza type 3 also causes LRT infection)
Others = respiratory syncytial virus and measles virus

18
Q

Describe Parainfluenza virus

A

Paramyxovirus family -ssRNA genome

  • RNA synthesis occurs in the cytoplasm
  • helical nucleocapsid
  • envelope contains hemagglutinin and neuraminidase (targets for immune system)
  • Transmission: large droplets/direct contact
  • incubation period 2-10 days
  • Pathogenesis = Infect, replicate in the ciliated epithelium of the respiratory tract
  • Short lived immunity; reinfection usually results in less severe illness.
19
Q

Describe Symptoms of Influenza

A

Myalgia, Headache, Fever, Shaking Chills,

  • Cough peaking between 3 and 5 days of illness
  • Cough, fatigue, and generalized weakness may last 2-6weeks
  • Increased severity of symptoms and incidence of complications usually seen in pandemic outbreaks
  • In temperate climates the infections peak during the winter months
  • Incubation lasts 2 days
20
Q

Describe the risk groups for complications to Influenza

A
  • Children younger than 2yo
  • adults 65 years or older
  • pregnant women and women up to 2 weeks postpartum
  • Persons with certain medical conditions
21
Q

What is the biggest side effect of Influenza

A
Pneumonia = inflammation of the lung parenchyma leading to abnormal gas exchange
Symptoms = Fever, chills, cough, pleuritic chest pain, increases respiratory rate, wheezes and crackles, hypoxia and cyanosis (severe cases)
22
Q

Describe Primary influenza virus pneumonia

A

Primary influenza virus pneumonia

  • -> usually influenza A
  • -> Symptoms = 1-4 days of influenza virus symtpoms, than increased cough, tachypnea, dyspnea, acute respiratory distress.
  • -> Sputum Gram Stain shows Abundant PMN cells w/o bacteria
23
Q

Describe Bacterial influenza-associated pneumonia

A

usually onset a week after influenza symptoms began

  • Symptoms = Influenza symptoms, which lessen, then followed by increased cough, return of fever, and respiratory distress
  • Sputum Gram stain may contain bacterial cause
  • Etiology: 1) S. Pneumoniae
    2) S. Aureus and H. Influenzae
    3) Others: N. meningitidis, other streptococcus and gram negative bacillus
24
Q

Cause of Influenza virus

A

Orthomyxovirus: segmented, -ssRNA virus genome, enveloped
Contains two proteins on surface: (important targets)
1) Hemagglutinin (H) = attachment and agglutinates RBC
2) Neuraminidase (N) = cleaves sialic acid, virion release/spread

25
Describe influenza virus changes
1) antigenic drift - small changes in H and N - driven by point mutations made by the polymerase during replication - epidemiological significant 2) Antigenic Shift - large changes in H and N - Driven by re-assortment of two viruses - Co-infection of the same cell - increased Risk for pandemics
26
describe the treatment for influenza
- Treated with antivirals within 48 hours of onset in people with no risk factors. - treated with antivirals if patient has risk factors for complications its beneficial to still give antivirals after 48 hours
27
Describe amantadine and Rimantadine
Anti-virals: ion channel blockers - blocks replication prior to genome release (M2) - effective against only influenza A viruses - however, influenza A may be resistant
28
Describe Zanamivir, oseltamivir, Peramivir
Anti-viral: Neuraminidase Inhibitors - Inhibits virion release and spread - Active against INFLUENZA A and B - for uncomplicated influenza, must be given in first 48 hours to reduce disease symptoms
29
Describe the use of Chemoprophylaxis in fighting influenza virus
- daily dos of anti-viral for duratino of flu season in the community - those at high risk for complications, which are vaccinated after the flu season has begun - Non immune health care workers and family members who care for those at high risk for influenza complications - poor match between vaccine and currently circulating strains
30
Describe SARS Coronavirus
Coronavirus family: enveloped, +ssRNA genome - more resistant to environmental conditions than Non-SARS CoV - Course of the disease: 1) Fever, Malaise, and myalgia 2) dry cough and shortness of breath 3) Most sever cases - adult respiratory distress syndrome (ARDS) and death within weeks - transmitted via Fecal-oral, close contact and aerosal routes (incubation is 2-10 days)
31
describe the SARS coronavirus control
Viral infection spread was controlled through stringent isolation and infection control measures
32
Describe Bronchiolitis
= inflammation of the bronchioles | SYMPTOMS: Expiratory wheezing, nasal flaring, air trapping, subcostal retractions, variable fever
33
Describe the cause of bronchiolitis
Respiratory syncytial virus (RSV) - most common cause of bronchiolitis and pneumonia in children less than 1yo - paramyxovirus family: enveloped, -ssRNA genome - Transmission through inhalation of large droplets, direct contact with respiratory secretions (very infectious) - incubation is 4-5days
34
describe the treatment of bronchiolitis
Aerosolized ribavirin (antiviral) - Mech of Action = inhibits nucleotide biosynthesis of mRNA capping and promotes hypermutation of the genome - Indicated for severe LRT RSV infection in special populations
35
Describe prevention of bronchiolitis
RSV passive immunoprophylaxis - given to infants before 32 weeks gestation and children under two 5 months before preceding RSV season AGENTS: 1) Palivizumab: chimeric human-mouse monoclonal anti-RSV antibody 2) RSIG: Pooled human immunoglobin, enriched for anti-RSV antibodies (less specific)